The Effect of Imatinib Mesylate for Newly Diagnosed Philadelphia Chromosome-Positive, Chronic-Phase Myeloid Leukemia in Sub-Saharan African Patients: The Experience of Côte d'Ivoire

Table 4

Hematologic and cytogenetic response according to Ph+ alone or additional chromosomal abnormalities.

Characteristics	Ph+ alone	Ph+ with additional abnormalities	𝑃
	𝑛.(%)(𝑛=25)	𝑛.(%); (𝑛=17)
CHR	22 (88)	10 (59)	.0357
MCyR	15 (60)	04 (24)	.043
CCyR	6 (24)	1 (6)	.210

CHR: complete hematologic response; MCyR: major cytogenetic response; CCY: complete cytogenetic response.